As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
The discovery of lead compounds is the process of turning the “hits” found in screening into “lead compounds” that can be further optimized. The lead compound may be a selected compound or a series of homologs, or it may be a compound derived from literature. However, for high-throughput screening, discrete, multiple series of emerging compounds may be produced, which requires selecting one of the series to continue research. This process is called “Hit to Lead”.
Tightly combine specific biological activity and ADME properties
Parallel biological evaluation and “developability” evaluation are essential
Dense data matrix
High degree of automation, high level of calculation and analysis
Cycle length is the key to success, and in vitro ADME analysis and calculation tools need to be integrated
Calculation tools can play an important role
If you want to outsource successfully, you need CRO to obtain all chemical/biological/compound/ADME data
From high-throughput screening to get ideal enough, multiple discrete series of compounds
Use fresh, high-purity samples to confirm biological activity and compound structure
In vitro activity <3μM, suitable functional activity
Reversibility
Feasible selective experiment
A single compound needs to synthesize a small compound library of the same series to confirm its activity
5-10 compounds are needed to confirm the diversity of choices
No unnecessary functional groups or chemical reaction groups
No toxic group
Modifiable chemical sites
Traceable physical properties
Molecular weight, solubility, polarity
ADME properties that can be analyzed for representative homologs
Particular attention is paid to proper oral absorption properties, solubility for intravenous injection and permeability of the central nervous system
ADME issues are tractable
*Special attention: Biological activity is usually the easiest property to optimize.
Lead compound optimization is the process of selecting a lead compound for preclinical evaluation and converting it into a candidate drug:
Most of the time is spent on solving ADME/T problems
Separate study of pharmacokinetics and pharmacodynamics duration of action can reap unexpected benefits
When modifying the lead compound, pay close attention to the changes in its physical and chemical properties
For compounds that are not selective, consider off-target effects/toxicity
Pay close attention to pre-clinical research requirements
The best way to gain experience is from actual work and reading drug development cases